A Study in Patients With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1538 participants.
Also called NCT01435616
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,538 participants
- Sponsor
- Registry
-
NCT01435616
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Brazil, Canada, Finland, Germany, Greece, Hungary, Israel, Italy, Lithuania, Mexico, New Zealand, Poland, Puerto Rico, Romania, Russia, Slovakia, South Africa, Spain, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01435616. Randomized; double masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-01 (actual). Results posted on 2018-04-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Patients With Type 2 Diabetes Mellitus
- Acronym
- IMAGINE 2
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Glargine
- Intervention (Drug)
- LY2605541
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01435616- Content hash
29549e04cb6857fcdb55f060426ac85790431ebc4d573121e342c64ffe7b902d